<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Body-clearable chromium nitride for synergetic photothermal and photodynamic treatment   - New Journal of Chemistry (RSC Publishing) DOI:10.1039/D0NJ03943H</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2020/nj/d0nj03943h"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":73,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(31),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(32),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),S=t(15),P=t(10),M=t("ee"),C=M.get("tracer"),N=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),P.on(p,r),M.on(d,o),b.on(l,o),P.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),S.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,N(!0)),w[v]("load",i,N(!0)),w[v]("popstate",function(){i(0,U>1)},N(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(32),a=t(31);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(31),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(28),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);return e.protocol&&"data"===e.protocol?void g("Ajax/DataUrl/Excluded"):void(e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this)))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=t(25).recordSupportability,y=NREUM.o.REQ,x=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof x&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof x&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;if("string"==typeof i?n=i:"object"==typeof i&&i instanceof y?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n),"data"!==this.params.protocol){var s=(""+(i&&i instanceof y&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}}),u.on("fetch-done",function(t,e){if(this.endTime=a.now(),this.params||(this.params={}),"data"===this.params.protocol)return void g("Ajax/DataUrl/Excluded");this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];if(0===(t||"").indexOf("data:"))return{protocol:"data"};var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(31),s=t(32),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(33);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?l("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&l("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(f&&f<r.startTime)return;var o=[r],i=a({});i&&o.push(i),l("lcp",o)}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||l("cls",[t])})}function a(t){var e=navigator.connection||navigator.mozConnection||navigator.webkitConnection;if(e)return e.type&&(t["net-type"]=e.type),e.effectiveType&&(t["net-etype"]=e.effectiveType),e.rtt&&(t["net-rtt"]=e.rtt),e.downlink&&(t["net-dlink"]=e.downlink),t}function s(t){if(t instanceof w&&!y){var e=Math.round(t.timeStamp),n={type:t.type};a(n),e<=h.now()?n.fid=h.now()-e:e>h.offset&&e<=Date.now()?(e-=h.offset,n.fid=h.now()-e):e=h.now(),y=!0,l("timing",["fi",e,n])}}function c(t){"hidden"===t&&(f=h.now(),l("pageHide",[f]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var f,u,d,p,l=t("handle"),h=t("loader"),m=t(30),v=t(23),w=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){u=new PerformanceObserver(r);try{u.observe({entryTypes:["paint"]})}catch(g){}d=new PerformanceObserver(o);try{d.observe({entryTypes:["largest-contentful-paint"]})}catch(g){}p=new PerformanceObserver(i);try{p.observe({type:"layout-shift",buffered:!0})}catch(g){}}if("addEventListener"in document){var y=!1,x=["click","keydown","mousedown","pointerdown","touchstart"];x.forEach(function(t){document.addEventListener(t,s,v(!1))})}m(c)}},{}],28:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(t)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],29:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],30:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],31:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],32:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],33:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(31),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!T++){var t=O.info=NREUM.info,e=m.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(E,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+O.offset],null,"api"),s("timing",["load",n]);var r=m.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=l+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===m.readyState&&i()}function i(){s("mark",["domContent",a()+O.offset],null,"api")}var a=t(26),s=t("handle"),c=t(31),f=t("ee"),u=t(29),d=t(21),p=t(23),l=d.getConfiguration("ssl")===!1?"http":"https",h=window,m=h.document,v="addEventListener",w="attachEvent",g=h.XMLHttpRequest,y=g&&g.prototype,x=!1;NREUM.o={ST:setTimeout,SI:h.setImmediate,CT:clearTimeout,XHR:g,REQ:h.Request,EV:h.Event,PR:h.Promise,MO:h.MutationObserver};var b=""+location,E={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1216.min.js"},R=g&&y&&y[v]&&!/CriOS/.test(navigator.userAgent),O=e.exports={offset:a.getLastTimestamp(),now:a,origin:b,features:{},xhrWrappable:R,userAgent:u,disabled:x};if(!x){t(20),t(27),m[v]?(m[v]("DOMContentLoaded",i,p(!1)),h[v]("load",r,p(!1))):(m[w]("onreadystatechange",o),h[w]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var T=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(32),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Yutuo Fu"/><meta name="DC.Creator" content="Le Wang"/><meta name="DC.Creator" content="Xiaoyu Chi"/><meta name="DC.Creator" content="F. Alvarado-Cesar"/><meta name="DC.Creator" content="Na An"/><meta name="DC.Creator" content="Yuanjun Song"/><meta name="DC.Creator" content="Yadong Wu"/><meta name="DC.Creator" content="Peng Zhang"/><meta name="DC.Creator" content="Chongshen Guo"/><meta name="DC.title" content="Body-clearable chromium nitride for synergetic photothermal and photodynamic treatment  "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2020/12/08"/><meta name="DC.Identifier" scheme="doi" content="10.1039/D0NJ03943H"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Body-clearable chromium nitride for synergetic photothermal and photodynamic treatment  "/><meta name="citation_author" content="Yutuo Fu"/><meta name="citation_author" content="Le Wang"/><meta name="citation_author" content="Xiaoyu Chi"/><meta name="citation_author" content="F. Alvarado-Cesar"/><meta name="citation_author" content="Na An"/><meta name="citation_author" content="Yuanjun Song"/><meta name="citation_author" content="Yadong Wu"/><meta name="citation_author" content="Peng Zhang"/><meta name="citation_author" content="Chongshen Guo"/><meta name="citation_online_date" content="2020/10/29"/><meta name="citation_date" content="2020"/><meta name="citation_journal_title" content="New Journal of Chemistry"/><meta name="citation_volume" content="44"/><meta name="citation_issue" content="46"/><meta name="citation_firstpage" content="20039"/><meta name="citation_lastpage" content="20046"/><meta name="citation_doi" content="10.1039/D0NJ03943H"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2020/nj/d0nj03943h"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2020/nj/d0nj03943h"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2020/nj/d0nj03943h"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2020/nj/d0nj03943h">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:d0nj03712e)" href="/en/content/articlehtml/2020/nj/d0nj03712e" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:d0nj03664a)" href="/en/content/articlehtml/2020/nj/d0nj03664a" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div> </div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/D0NJ03943H">10.1039/D0NJ03943H</a>
(Paper)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/1369-9261/1998">New J. Chem.</a></span>, 2020, <strong>44</strong>, 20039-20046</div><h1 id="sect184"><span class="title_heading">Body-clearable chromium nitride for synergetic photothermal and photodynamic treatment<a title="Select to navigate to footnote" href="#fn1">†</a></span></h1><p class="header_text">
      <span class="bold">
        
          
            Yutuo 
            Fu<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
        
      </span><sup><span class="sup_ref italic">ab</span></sup>, 
      <span class="bold">
        
          
            Le 
            Wang<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Xiaoyu 
            Chi<a title="Select to navigate to footnote" href="#fn2">‡</a>
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            F. 
            Alvarado-Cesar
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Na 
            An
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Yuanjun 
            Song
          
        
      </span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Yadong 
            Wu
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Yadong Wu (orcid.org/0000-0003-0184-1453) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0003-0184-1453"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span><sup><span class="sup_ref italic">a</span></sup>, 
      <span class="bold">
        
          
            Peng 
            Zhang
          
        
      </span>*<sup><span class="sup_ref italic">c</span></sup><span class="bold"> and </span>
      <span class="bold">
        
          
            Chongshen 
            Guo
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Chongshen Guo (orcid.org/0000-0002-8000-7434) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-8000-7434"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<sup><span class="sup_ref italic">a</span></sup>
      <br/><a id="affa"><sup><span class="sup_ref italic">a</span></sup></a><span class="italic">School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China. E-mail: <a href="mailto:chongshenguo@hit.edu.cn">chongshenguo@hit.edu.cn</a></span>
      <br/><a id="affb"><sup><span class="sup_ref italic">b</span></sup></a><span class="italic">Heilongjiang Provincial Hospital, Harbin Institute of Technology, Harbin 150001, China</span>
      <br/><a id="affc"><sup><span class="sup_ref italic">c</span></sup></a><span class="italic">Center for Precision Engineering, Harbin Institute of Technology, Harbin 150001, China. E-mail: <a href="mailto:zp@hit.edu.cn">zp@hit.edu.cn</a></span>
    </p><div id="art-admin"><span class="italic bold">Received 
      6th August 2020
    </span><span class="bold italic">, Accepted 28th October 2020</span></div><p class="bold italic">First published on 29th October 2020</p><hr/><div class="abstract"><h2>Abstract</h2><p>Phototherapy is one of most promising antitumor alternatives that realizes the photoablation of solid tumors with the help of photoactive materials. However, the long-term <span class="italic">in vivo</span> toxic potential of the non-degradable photoactive material hinders it from clinical applications. In this work, a body-clearable nanomaterial of chromium nitride was applied for synergetic phototherapy. Chromium nitride is a broad-spectra near infrared (NIR) absorbent that can be excited by NIR to generate hyperthermia and reactive oxygen species (ROS) simultaneously. As a result, the dual actions of photothermal and photodynamic treatment outcomes could be achieved by this single matter. The <span class="italic">in vitro</span> cell experiments proved a better antitumor outcome of the synergetic phototherapy action over the single-role photothermal or photodynamic therapy. More interestingly, <span class="italic">in vivo</span> metabolic studies disclosed that the overall <span class="italic">in vivo</span> content of chromium nitride dropped significantly after intravenous injection, and the excretion of chromium nitride was found in urine and feces. Consequently, this work presents a new idea for precise and low side-effect phototherapy modality.</p></div><hr/>
    
      
      <h2 id="sect276"><span class="a_heading">1. Introduction</span></h2>
      <span>Cancer is one of the leading causes of human death worldwide. Nowadays, clinical antitumor treatments mainly involve surgery, radiotherapy or chemotherapy. Surgery is very effective for early-stage un-metastasized tumors; however, it is incapable of addressing diffuse tumors or some inoperable tissues.<a title="Select to navigate to reference" href="#cit1"><sup><span class="sup_ref">1,2</span></sup></a> Chemotherapy relies on antitumor drugs to inhibit the cell cycle of cancer cells and ultimately to eliminate tumors. Nonetheless, the poor targeting behavior of chemotherapeutic drugs often results in the unwanted biodistribution of drugs in normal organs as well and consequently incurs high side-effects. Another common antitumor treatment is radiotherapy, which gives rise to massive on-site reactive oxygen species (ROS) to destroy solid tumors under the effect of short-wave irradiation. However, these radioactive rays are very harmful for normal tissue as well as a teratogenic risk.<a title="Select to navigate to reference" href="#cit3"><sup><span class="sup_ref">3,4</span></sup></a> Recently, phototherapy has emerged as a promising alternative to the traditional oncotherapies.<a title="Select to navigate to reference" href="#cit5"><sup><span class="sup_ref">5–9</span></sup></a> For achieving a better penetration depth, near infrared light (NIR) of 800–1400 nm is usually applied for the phototherapy due to the limited light scattering and absorption by the body. Under NIR irradiation, the photoactive materials at the tumor site could generate hyperthermia (photothermal therapy, PTT) or ROS (photodynamic therapy, PDT) to damage the cancer cells.<a title="Select to navigate to reference" href="#cit10"><sup><span class="sup_ref">10–13</span></sup></a> Obviously, phototherapy shows a higher superiority to traditional methods. First, phototherapy can often result in an immungentic cell death effect and trigger the host antitumor immune effect; that is, treating one tumor but eliminating all tumors.<a title="Select to navigate to reference" href="#cit14"><sup><span class="sup_ref">14–16</span></sup></a> This is much better than the surgery method. Second, these photoactive materials as photothermal agents or photosensitizers are nontoxic in the absence of external NIR. Consequently, the photoablation effect only takes place on-site where the NIR and photoactive materials are both available. Compared with chemotherapy, the side-effects of phototherapy are quite low because these non-excited photoactive materials at normal organs have lower cytotoxicity than chemotherapeutic drugs.<a title="Select to navigate to references" href="#cit17"><sup><span class="sup_ref">17</span></sup></a> Finally, NIR is a part of sunlight and makes up about 50% of solar energy, and thus the health threat from NIR is very limited in contrast to the radioactive rays used in radiotherapy.<a title="Select to navigate to reference" href="#cit18"><sup><span class="sup_ref">18,19</span></sup></a></span>
      <p class="otherpara">Although great advances have been made in the area of phototherapy, there are still some problems that must be paid attention to. The first important one is the long-term <span class="italic">in vivo</span> risk of photoactive materials. After the phototherapy, the photoactive materials would be left <span class="italic">in vivo</span> and some materials are even non-biodegradable, such as carbon-based materials and ceramic-like materials. The unknown long-term risks, such as related to teratogenesis, allergization, and oncogenicity, hinder the development of phototherapy in clinical applications.<a title="Select to navigate to references" href="#cit20"><sup><span class="sup_ref">20</span></sup></a> Hence, ideal photothermal agents or photosensitizers should be body-clearable after the treatment. Second, a synergetic PTT and PDT treatment is highly required, especially for single-material mediated treatments. The PDT treatment outcome often decreases with time alongside the tissue oxygen depletion and the weakening of the generation of ROS. Therefore, PDT treatment is an early-effective modality. On the contrary, the antitumor effect of PTT treatment increases with time alongside the temperature elevation, and meanwhile, the PTT outcome has no relationship with tissue oxygen. Consequently, PDT and PTT are complementary antitumor modalities that can induce dual antitumor effects.<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a> So far, some researchers have made important contributions to the synergetic PTT/PDT treatment <span class="italic">via</span> the integration of photothermal materials and photosensitizers into a complex nanosystem. However, this brings the problems of mutual interference and a possible absorption mismatch between the photothermal material and photosensitizer, as all as a complex synthesis, <span class="italic">in vivo</span> disintegration, and so forth.<a title="Select to navigate to references" href="#cit21"><sup><span class="sup_ref">21</span></sup></a></p>
      <p class="otherpara">In this work, chromium nitride (Cr<small><sub>2</sub></small>N) nanoparticles were selected as a body-clearable phototherapeutical agent for the synergetic PTT/PDT treatment. Chromium nitride shows a wide photoabsorption in the biological window of 800–1400 nm. More importantly, both hyperthermia and ROS could be generated by this singe-matter of Cr<small><sub>2</sub></small>N when subjected to NIR irradiation, thus realizing the desired PTT and PDT outcome simultaneously. An <span class="italic">in vivo</span> biodegradation study revealed that the Cr<small><sub>2</sub></small>N could be excreted by urine and feces and the <span class="italic">in vivo</span> content of Cr<small><sub>2</sub></small>N in the major organs clearly decreased with time. Moreover, the histology and hematological analyses verified the adequate biosafety of Cr<small><sub>2</sub></small>N. Consequently, this work presents a plausible way to achieve synergetic phototherapy with a single biodegradable material.</p>
    
    
      
      <h2 id="sect303"><span class="a_heading">2. Experimental</span></h2>
      
        
        <h3 id="sect306"><span class="b_heading">2.1 Materials</span></h3>
        <span>Cr<small><sub>2</sub></small>N nanoparticles were obtained from Shanghai Chaowei Nano Technology Co. Ltd. Cr<small><sub>2</sub></small>N nanoparticles were synthesized by laser plasma gas-phase synthesis with metal Cr powder as a Cr resource under an NH<small><sub>3</sub></small> atmosphere. Live–dead stains of calcein acetoxymethyl ester (Calcein-AM) and propidium iodide (PI), ROS indicators of 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) and 1,3-diphenylisobenzofuran (DPBF), and 3-(4,5-dimethylthialzol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were bought from Sigma-Aldrich. Female BALB/C nude mice were obtained from Vitalriver Experimental Animal Technical Co., Ltd (Beijing).</span>
      
      
        
        <h3 id="sect313"><span class="b_heading">2.2 Characterizations</span></h3>
        <span>The structural feature and elemental analysis of the samples were studied by transmission electron microscopy (TEM, JEM 2100F). XRD analysis was performed by X-ray diffractometry (Smartlab9, 40 kV, 150 mA). The chemical states and elemental composition of the samples were carried out by X-ray photoelectron energy spectroscopy (ThermoFisher K-Alpha). UV-Vis-NIR spectrometry (U-2600, Shimadzu, Japan) was used for the optical absorbance test of both the powders and solutions. Hematological analysis was performed on an HF-3800 automatic blood analyzer. For recording the temperature profile of the photo-irradiated solutions or mice, an infrared camera (FLIR E6) was applied.</span>
      
      
        
        <h3 id="sect317"><span class="b_heading">2.3 Photothermal conversion tests</span></h3>
        <span>First, 0.4 mL Cr<small><sub>2</sub></small>N aqueous dispersion (0.5 mg mL<small><sup>−1</sup></small>) was set in a quartz tube and irradiated with an NIR laser of 808 nm (1.5 W cm<small><sup>−1</sup></small>) for 10 min. Then, it was allowed to cool naturally for another 10 min. During the whole process, the temperature variations were monitored with an infrared camera.</span>
      
      
        
        <h3 id="sect324"><span class="b_heading">2.4 ROS detection</span></h3>
        <span>ROS generation detection was performed with a probe of BPDF first to check the ROS level in the solution. Next, 30 μL DPBF solution in <span class="italic">N</span>,<span class="italic">N</span>-dimethylformamide (1 mg mL<small><sup>−1</sup></small>) was added into 3 mL Cr<small><sub>2</sub></small>N aqueous dispersion (0.5 mg mL<small><sup>−1</sup></small>). Then, the resultant above solution was irradiated with an 808 nm laser (1.5 W cm<small><sup>−1</sup></small>) for 1 h and the optical absorbance value at 420 nm was recorded at 5, 10, 15, 30, and 60 min post irradiation. Meanwhile, the Cr<small><sub>2</sub></small>N-mediated ROS level in the solution was checked by electron spin resonance (ESR) tests as well. Here, 3 mL Cr<small><sub>2</sub></small>N aqueous dispersion (0.5 mg mL<small><sup>−1</sup></small>) with the addition of TEMP underwent NIR irradiation for 20 min and then the ESR spectra were obtained. Fluorescence visualization of the intracellular ROS level was realized by the H2DCFDA probe. HepG2 cells seeded in 6-well plates were treated with 0.5 mg mL<small><sup>−1</sup></small> Cr<small><sub>2</sub></small>N aqueous dispersion for 6 h. Then, 10 min irradiation was applied to the cells, which were then stained with H2DCFDA (5 mg mL<small><sup>−1</sup></small>, 50 μL) for 1 h and finally imaged on a fluorescence microscope. In this part, the positive control was H<small><sub>2</sub></small>O<small><sub>2</sub></small> (50 mM, 150 μL)-treated cells. The negative control groups were cells that had only received NIR irradiation and cells treated with Cr<small><sub>2</sub></small>N aqueous dispersion. For investigating the ROS quenching effect of vitamin C (Vc), 100 μL (5 mM) Vc solution was introduced while the other parameters were kept unchanged.</span>
      
      
        
        <h3 id="sect343"><span class="b_heading">2.5 
          <span class="italic">In vitro</span> cell experiments</span></h3>
        <span>The cytotoxicity was evaluated with a standard MTT method. First, HepG2 and HUVEC cells seeded in 96-well plates were treated with varied concentrations of Cr<small><sub>2</sub></small>N solution for 24 h. Then, the cells were rinsed with PBS to remove the excessive Cr<small><sub>2</sub></small>N and MTT solution was added (5 mg mL<small><sup>−1</sup></small>, 20 μL per well). After 4 h incubation, 150 μL dimethyl sulfoxide was added to dissolve formazan for 30 min. The absorbance at 490 nm was recorded on a microplate reader. The trials were conducted three times and the cell viabilities were evaluated with regard to the untreated cells.</span>
        <p class="otherpara">To study the <span class="italic">in vitro</span> phototherapy efficiency, the cells were divided into six groups: (1) untreated cells, (2) cells treated with NIR irradiation (1.5 W cm<small><sup>−1</sup></small>, 10 min), (3) cells treated with Cr<small><sub>2</sub></small>N aqueous dispersion (0.5 mg mL<small><sup>−1</sup></small>), (4) cells treated with NIR + Cr<small><sub>2</sub></small>N + ice bath, (5) cells treated with NIR + Cr<small><sub>2</sub></small>N + Vc (100 μL, 5 mM), and (6) cells treated with NIR and Cr<small><sub>2</sub></small>N. Then, the cell viabilities of the above groups were determined by MTT assay as well. The live–dead staining on cells were conducted with Calcein-AM and PI. Cells after treatment were co-stained with Calcein-AM (5 μL, 1 μg mL<small><sup>−1</sup></small>) and PI (200 μL, 20 μg mL<small><sup>−1</sup></small>) and imaged by fluorescence microscopy.</p>
      
      
        
        <h3 id="sect361"><span class="b_heading">2.6 
          <span class="italic">In vivo</span> antitumor study</span></h3>
        <span>All the animal experiments and operations were conducted according to the criteria of the National Regulation of China for the Care and Use of Laboratory Animals and Guidelines for the Care and Use of Experimental Animals of the Heilongjiang Provincial Congress, and approved by the Ethics Research Committee of the Harbin Institute of Technology (No. IACUC-2019009). The HepG2-tumor model was established on nude mice <span class="italic">via</span> the injection of 1 × 10<small><sup>7</sup></small> HepG2 cells in 50% matrigel on the left flank leg of the mice. When the volume of the tumor reached about 200 mm<small><sup>3</sup></small>, the mice were randomly divided into five groups (<span class="italic">n</span> = 5 in each group): group 1, untreated control mice; group 2, Cr<small><sub>2</sub></small>N treated mice (intratumoral injection with 200 μL, 0.5 mg mL<small><sup>−1</sup></small> Cr<small><sub>2</sub></small>N solution); group 3, NIR-irradiated mice (1.5 W cm<small><sup>−1</sup></small>, 10 min); group 4, Cr<small><sub>2</sub></small>N injection + NIR irradiation + Vc injection (5 mM, 100 μL); and group 5, Cr<small><sub>2</sub></small>N injection + NIR irradiation. All the treatments were performed only once. After the treatment, the tumor volume and body weight were measured every other day. The tumor volume was calculated as <span class="italic">V</span> = (tumor length) × (tumor width)<small><sup>2</sup></small>/2. The antitumor outcome was reflected by the relative tumor volume of <span class="italic">V</span>/<span class="italic">V</span><small><sub>0</sub></small>, where <span class="italic">V</span><small><sub>0</sub></small> is the tumor volume before treatment and <span class="italic">V</span> is the tumor volume at a certain day post treatment.</span>
      
      
        
        <h3 id="sect384"><span class="b_heading">2.7 Histology analysis</span></h3>
        <span>At the 14th day post treatment, the mice were euthanatized and the tumor and major organs (spleen, liver, kidney, heart, lung) were harvested for the H&amp;E staining. Tissues were saved in 4% paraformaldehyde solution and stained with H&amp;E. The images of the tissues were observed by an Olympus BX53 microscope.</span>
      
      
        
        <h3 id="sect388"><span class="b_heading">2.8 
          <span class="italic">In vivo</span> biodistribution and excretion</span></h3>
        <span>Mice were intravenously injected with Cr<small><sub>2</sub></small>N solution (1 mg mL<small><sup>−1</sup></small>, 100 μL). At different times post injection, the mice were sacrificed and the major organs of the heart spleen, liver, kidney, heart, lung, brain, and bone were boiled in 68 wt% HNO<small><sub>3</sub></small> solution. Then, the ICP-OES analysis was performed for confirming the content of Cr element. Similarly, the Cr content in the urine and feces of mice was tested by ICP-OES as well. The statistical analysis was performed on five mice for each experimental point.</span>
      
      
        
        <h3 id="sect396"><span class="b_heading">2.9 Statistical analysis</span></h3>
        <span>The statistical significance was obtained with the analysis of variance (ANOVA) and two-tail Student's <span class="italic">t</span> test. In this work, *: <span class="italic">p</span> &lt; 0.05, **: <span class="italic">p</span> &lt; 0.01, <span class="italic">p</span> value &lt; 0.05 were considered significant.</span>
      
    
    
      
      <h2 id="sect404"><span class="a_heading">3. Results and discussion</span></h2>
      <span>In this work, we employed Cr<small><sub>2</sub></small>N nanoparticles for the synergetic PDT/PTT treatment in virtue of its unique photoactive performance and body-clearable property. A shown in the <a title="Select to navigate to figure" href="#imgfig1">Fig. 1a, d–f</a> and Fig. S1 (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), these Cr<small><sub>2</sub></small>N nanoparticles were sheet-like and their dimensions were in the range of 30–100 nm. In addition, the hydrodynamic diameter of the Cr<small><sub>2</sub></small>N nanoparticles was determined by dynamic light scattering to be 234 nm, which was bigger than in the TEM observation, illustrating a slight aggregation between the particles in water. (Fig. S2, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>). The HR-TEM image showed clear and regular lattice fringes, indicating the high crystallinity. In addition, the crystal lattice spacing was 0.214 nm, which was in accordance with the (1 1 1) facet of Cr<small><sub>2</sub></small>N (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1b</a>). The EDS analysis in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1c–f</a> disclosed that the sample consisted of Cr and N elements. Then, the crystal nature of the sample was investigated by XRD. In <a title="Select to navigate to figure" href="#imgfig1">Fig. 1g</a>, all of the detectable diffractive peaks well matched the Cr<small><sub>2</sub></small>N (standard card: 35-0803) and no impurity could be found. Then, the XPS survey was carried out on Cr 3p and N 1s orbits. As displayed in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1h</a>, the spin–orbit coupling doublet of Cr 2p<small><sub>3/2</sub></small> and Cr 2p<small><sub>1/2</sub></small> were seen at binding energies of 575.7 and 585.8 eV, which were consistent with the typical character of Cr<small><sub>2</sub></small>N species. Meanwhile, the characteristic Cr<small><sub>2</sub></small>N peak was found in the N 1s spectra at 396.6 eV as well (<a title="Select to navigate to figure" href="#imgfig1">Fig. 1g</a>). In addition, another weak shoulder peak at 397.9 eV in the N 1s spectra illustrated the presence of CrO<small><sub><span class="italic">x</span></sub></small>N<small><sub><span class="italic">y</span></sub></small> to a certain degree according to previous reports.<a title="Select to navigate to reference" href="#cit22"><sup><span class="sup_ref">22,23</span></sup></a> Considering that there was no impurity in the XRD pattern, a slight oxidation may happen on the surface of Cr<small><sub>2</sub></small>N to form an amorphous layer or presence of superficially adsorbed oxygen. Anyway, we confirmed the Cr<small><sub>2</sub></small>N nature of the sample in this work on the basis of the above characterizations in terms of the crystal nature, chemical valence, and elemental composition. Finally, Cr<small><sub>2</sub></small>N could be well dispersed in water, PBS, and culture medium as evidenced by there being no macroscopical sedimentation (Fig. S3, ESI<a title="Select to navigate to footnote" href="#fn1">†</a>).</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-f1.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Characterizations of Cr<small><sub>2</sub></small>N. (a) TEM image, (b) HR-TEM image, (c) EDS profile, (d–f) EDS mapping, (g) XRD pattern, (h) XPS spectra of Cr 3p and (i) N 1s.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Being a photoactive material for NIR-driven phototherapy, the optical absorbance in the biological window is a basic requirement. In this work, we first measured the photoabsorption of powder Cr<small><sub>2</sub></small>N. As disclosed in <a title="Select to navigate to figure" href="#imgfig2">Fig. 2a</a>, wide and strong absorbance across the ultraviolet, visible, and NIR region was seen for the Cr<small><sub>2</sub></small>N sample. This led to its high absorbance value above 0.85 in all wavelengths, including the desired NIR window of 800–1400 nm. Further, the absorbance of Cr<small><sub>2</sub></small>N aqueous dispersion was tested with water as a background. In <a title="Select to navigate to figure" href="#imgfig2">Fig. 2b</a>, the photoabsorption of Cr<small><sub>2</sub></small>N solution linearly increased with the concentration of the sample. Afterwards, the photothermal conversion effect was carried out on 0.5 mg mL<small><sup>−1</sup></small> Cr<small><sub>2</sub></small>N solution. Under NIR irradiation of 1.5 W cm<small><sup>−2</sup></small> (808 nm), the Cr<small><sub>2</sub></small>N solution showed a higher and faster temperature elevation as compared with pure water, suggesting the excellent photothermal properties of Cr<small><sub>2</sub></small>N even at such a low concentration (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2c</a>). The temperature changes in the cooling stage were applicable for calculation of the heat transfer <span class="italic">hS</span> between container and surrounding, where <span class="italic">h</span> is the heat transfer coefficient and <span class="italic">A</span> is the surface area of the quartz tube. According to a well-established method, the photothermal conversion efficiency (<span class="italic">η</span>) could be calculated by <a title="" href="#eqn1">eqn (1)</a>.<a title="Select to navigate to references" href="#cit24"><sup><span class="sup_ref">24</span></sup></a><table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn1"/><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-t1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-t1.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-t1.gif"/></a></td><td class="rightEqn">(1)</td></tr></table>where, <span class="italic">I</span> is the laser power and <span class="italic">A</span><small><sub>808</sub></small> is the absorbance of Cr<small><sub>2</sub></small>N dispersion at 808 nm; <span class="italic">T</span><small><sub>max</sub></small> is the equilibrium temperature after 10 min irradiation; <span class="italic">T</span><small><sub>surr</sub></small> is the ambient temperature; and <span class="italic">Q</span><small><sub>dis</sub></small> is the heat dissipation of light absorbed by the quartz sample cell itself, whose value is so small as to be negligible. In this work, <span class="italic">I</span> was 0.424 W (1.5 W cm<small><sup>−1</sup></small>, spot diameter = 6 mm), <span class="italic">T</span><small><sub>max</sub></small> was 44.3 °C, <span class="italic">T</span><small><sub>surr</sub></small> was 28 °C, and <span class="italic">A</span><small><sub>808</sub></small> was 0.52. Then, the only unknown value was <span class="italic">hS</span>, which could be determined by the following equations. First, one needs to define a dimensionless quantity of <span class="italic">θ</span> as per <a title="" href="#eqn2">eqn (2)</a>.<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn2"/><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-t2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-t2.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-t2.gif"/></a></td><td class="rightEqn">(2)</td></tr></table></p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-f2.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">Photoabsorption and photothermal behavior of Cr<small><sub>2</sub></small>N. (a) Powder absorbance, (b) absorbance of dispersion, (c) photothermal conversion curve (808 nm, 1.5 W cm<small><sup>−2</sup></small>), and (d) plot of cooling time <span class="italic">versus</span> −ln<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>θ.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">In the natural cooling stage, the cooling time <span class="italic">t</span> and <span class="italic">θ</span> follow <a title="" href="#eqn3">eqn (3)</a> and the time constant (<span class="italic">τ</span><small><sub>s</sub></small>) could be obtained by plotting −ln<img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/><span class="italic">θ versus t</span>. Obviously, the slope value was <span class="italic">τ</span><small><sub>s</sub></small>, which was 212.93 s in this work according to the <a title="Select to navigate to figure" href="#imgfig2">Fig. 2d</a>.<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn3"/><span id="eqn3"><span class="italic">t</span> = −<span class="italic">τ</span><small><sub>s</sub></small><img class="charmap" src="https://www.rsc.org/images/entities/char_2009.gif" alt="[thin space (1/6-em)]"/>ln(<span class="italic">θ</span>)</span></td><td class="rightEqn">(3)</td></tr></table></p>
      <p class="otherpara">Then, the <span class="italic">hS</span> could be calculated by <a title="" href="#eqn4">eqn (4)</a> (<span class="italic">hS</span> = 7.9 mW °C<small><sup>−1</sup></small>), where <span class="italic">m</span> is the mass of solution (0.4 g) and <span class="italic">C</span><small><sub>p</sub></small> is the heat capacity of water (4.2 J g<small><sup>−1</sup></small>).<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn4"/><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-t3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-t3.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-t3.gif"/></a></td><td class="rightEqn">(4)</td></tr></table></p>
      <p class="otherpara">Finally, the photothermal conversion efficiency (<span class="italic">η</span>) of Cr<small><sub>2</sub></small>N was calculated as 43.4%, which was higher than most of the previously reported inorganic nanomaterials, such as Au nanorods (22%), Cu<small><sub>2−<span class="italic">x</span></sub></small>Se nanocrystals (22%), black phosphorus (28.4%), Pd nanosheets (27.8%), Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> clusters (16.9%), and MoO<small><sub>3−<span class="italic">x</span></sub></small> nanospheres.<a title="Select to navigate to reference" href="#cit25"><sup><span class="sup_ref">25–30</span></sup></a></p>
      <p class="otherpara">Our above efforts confirmed the photothermal behavior of Cr<small><sub>2</sub></small>N nanoparticle under NIR irradiation. Until now, most photothermal agents are nanomaterials that perform the single role of the photothermal effect. Our previous studies found that some metallic inorganic materials could act as photosensitizers as well. The localized surface plasmon resonance (LSPR) effect, hot electron effect, or phonon–polaron hopping action could facilitate the generation of free electrons to further give rise to ROS.<a title="Select to navigate to reference" href="#cit18"><sup><span class="sup_ref">18,19</span></sup></a> Among various ROS, singlet oxygen has been verified to be the most effective one to treat tumors.<a title="Select to navigate to references" href="#cit31"><sup><span class="sup_ref">31</span></sup></a> In this work, Cr<small><sub>2</sub></small>N nanoparticles were check by the photosensitive properties of ROS generation. First, the NIR-triggered generation of singlet oxygen was realized by the DPBF probe, which could be degraded by singlet oxygen and result in an absorbance loss of its characteristic absorption at 420 nm. Thus, the photodegradation performance of DPBF could well reflect the ROS level.<a title="Select to navigate to reference" href="#cit20"><sup><span class="sup_ref">20,21</span></sup></a> As shown in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>, only NIR irradiation without Cr<small><sub>2</sub></small>N gave very limited DPBF degradation as the control. In sharp contrast, Cr<small><sub>2</sub></small>N could mediate distinct DPBF degradation under irradiation, corresponding to massive ROS production. Herein, we also introduced a ROS quencher of Vc in this work. In <a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>, it can be seen that the addition of Vc could well inhibit the degradation of Vc as a result of ROS quenching. In this work, the photodegradation of DPBF followed the pseudo-first-order reaction kinetic model as shown in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3b</a>. It is well known that the thermolysis of organic compounds often follows the pseudo-zero-order reaction kinetic model, while the ROS-related photodegradation of organic compounds is a pseudo-first-order reaction. Hence, this further verified the production of ROS by Cr<small><sub>2</sub></small>N for the DPBF degradation, instead of by thermolysis. Next, the generation of singlet oxygen was checked by ESR analysis. In <a title="Select to navigate to figure" href="#imgfig3">Fig. 3c</a>, the typical adduct of TEMP-<small><sup>1</sup></small>O<small><sub>2</sub></small> was discerned, thus further verifying the ROS generation. Finally, the intracellular ROS level was examined with a probe of H2DCFDA, which is a non-fluorescent molecule. After being oxidized by singlet oxygen, H2DCFDA would turn into a green fluorescent molecule. By this way, the visualization of ROS could be realized by fluorescent imaging. In <a title="Select to navigate to figure" href="#imgfig3">Fig. 3d</a>, the untreated cells and Cr<small><sub>2</sub></small>N-treated cells showed no green fluorescence, thus suggesting no ROS production. As to NIR-irradiated cells (without Cr<small><sub>2</sub></small>N), bits of green spots emerged. Massive green fluorescence could be seen in the NIR-excited Cr<small><sub>2</sub></small>N group and in the positive control of the H<small><sub>2</sub></small>O<small><sub>2</sub></small>-treated control, which once again proved the photosensitive properties of Cr<small><sub>2</sub></small>N. Similarly to the finding in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>, Vc could well quench the singlet oxygen as there was no green fluorescence seen with the introduction of Vc. Consequently, this work presents a novel Cr<small><sub>2</sub></small>N that has the dual identity of a photothermal agent and photosensitizer. Obviously, it showed great superiority to the other synergetic phototherapy systems with multicomponents. The Cr<small><sub>2</sub></small>N in this work could generate ROS and hyperthermia simultaneously under a single wavelength laser, which avoids the mismatch of incident NIR for exciting individual photothermal agents and photosensitizers, respectively. Compared to the other single-functional photoactive material, Cr<small><sub>2</sub></small>N exhibited higher photon utilization and dual antitumor effects. Moreover, a better <span class="italic">in vivo</span> robustness of single Cr<small><sub>2</sub></small>N is another merit with regard to the multicomponent system. Taken together, Cr<small><sub>2</sub></small>N displayed potent NIR-triggered photothermal and photosensitive performances.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-f3.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">Detection of photosensitive properties of Cr<small><sub>2</sub></small>N. (a) Photodegradation of DPBF and (b) first order kinetics behavior of DPBF degradation, (c) ESR spectra of TEMP-<small><sup>1</sup></small>O<small><sub>2</sub></small> adduct spin-trapping, (d) fluorescent image of cells after different treatments (cells were stained with H2DCFDA, the bar inset is 200 μm).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Being a metalloid material, the free electron density of Cr<small><sub>2</sub></small>N was high and it had a localized surface plasmon resonance (LSPR) property. NIR irradiation would trigger LSPR in Cr<small><sub>2</sub></small>N and massive “hot electrons” would be excited and transferred, forming matched holes simultaneously.<a title="Select to navigate to reference" href="#cit32"><sup><span class="sup_ref">32,33</span></sup></a> Then, the electrons would react with dissolved oxygen to form ROS <span class="italic">via</span> a classic photophysical process as that shown in the photocatalytic reaction as below. The electrons would be captured by dissolved oxygen to form ˙O<small><sub>2</sub></small><small><sup>−</sup></small>, which would subsequently react with H<small><sup>+</sup></small> ions to produce ˙HO<small><sub>2</sub></small>. On the other hand, holes on the surface of Cr<small><sub>2</sub></small>N would oxidize OH<small><sup>−</sup></small> into ˙OH. Finally, the reaction between ˙O<small><sub>2</sub></small><small><sup>−</sup></small> and ˙OH would give rise to singlet oxygen (<small><sup>1</sup></small>O<small><sub>2</sub></small>) and OH<small><sup>−</sup></small>.<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn5"/><span id="eqn5">O<small><sub>2</sub></small> + e<small><sup>−</sup></small> → ˙O<small><sub>2</sub></small><small><sup>−</sup></small></span></td><td class="rightEqn">(5)</td></tr></table><table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn6"/><span id="eqn6">˙O<small><sub>2</sub></small><small><sup>−</sup></small> + H<small><sup>+</sup></small> → ˙HO<small><sub>2</sub></small></span></td><td class="rightEqn">(6)</td></tr></table><table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn7"/><span id="eqn7">Cr<small><sub>2</sub></small>N* + h<small><sup>+</sup></small> + OH<small><sup>−</sup></small> → ˙OH</span></td><td class="rightEqn">(7)</td></tr></table><table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn8"/><span id="eqn8">˙O<small><sub>2</sub></small><small><sup>−</sup></small> + ˙OH → <small><sup>1</sup></small>O<small><sub>2</sub></small> + OH<small><sup>−</sup></small></span></td><td class="rightEqn">(8)</td></tr></table></p>
      <p class="otherpara">All of the above radical formations were partly proved by the ESR results in <a title="Select to navigate to figure" href="#imgfig3">Fig. 3b</a> and Fig. S4 (ESI<a title="Select to navigate to footnote" href="#fn1">†</a>), which gave evidence of ˙OH and <small><sup>1</sup></small>O<small><sub>2</sub></small> in the ESR test.</p>
      <p class="otherpara">Prior to the phototherapy, the cytotoxicity test was conducted with a standard MTT assay. Human malignant tumor cells of HepG2 and human umbilical vein endothelial cells (HUVEC) were incubated with Cr<small><sub>2</sub></small>N of different concentrations for 24 h. As shown in the <a title="Select to navigate to figure" href="#imgfig4">Fig. 4a and b</a>, the cell viabilities were higher than 80% even when incubated with as high as 1 mg mL<small><sup>−1</sup></small> Cr<small><sub>2</sub></small>N solution, indicating an adequate biocompatibility in the absence of NIR excitation. Next, the <span class="italic">in vitro</span> cancer cell-killing efficiency was evaluated with the MTT assay as well. Cells in 96-well plates received different treatments and then the cell viabilities were recorded. In <a title="Select to navigate to figure" href="#imgfig4">Fig. 4c</a>, the cells subjected to only NIR irradiation or Cr<small><sub>2</sub></small>N incubation showed nearly no cell death. As to the phototherapeutic treatment, we conducted PDT, PTT, and synergetic PDT/PTT treatments. Considering that both hyperthermia and ROS would be produced by NIR-excited Cr<small><sub>2</sub></small>N, it is necessary to remove one of them respectively to examine the single action of PDT or PTT. Our above results evidenced the ROS quenching effect of Vc, which could be given to remove the ROS. In this way, the single PTT efficiency was proved to be 61% cancer cells death. On the other hand, the ice bath was applied to ensure the temperature of the irradiated area was below 20 °C, and thus the PTT action was eliminated through this. The PDT could contribute to 36% cancer cells death. As expected, the synergetic PDT/PTT treatment gave the highest cell death of 89.4%. Then, live–dead staining was performed on 6-well plates with Calcein-AM (live cells, green fluorescence) and PI (dead cells, red fluorescence). <a title="Select to navigate to figure" href="#imgfig4">Fig. 4d</a> clearly shows the remarkable cancer cell death circle within the phototherapy area, while the other three control groups showed live cells only. The above <span class="italic">in vitro</span> results verified the synergistic PDT and PTT outcome of Cr<small><sub>2</sub></small>N.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-f4.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">Cell viability of (a) HepG2 and (b) HUVEC after incubation with Cr<small><sub>2</sub></small>N for 24 h, (c) cell viability of HepG2 cells after different treatments (*<span class="italic">P</span> &lt; 0.05, Student <span class="italic">t</span> test), (d) live–dead staining of cells after different treatments.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">The <span class="italic">in vivo</span> antitumor study was established on HepG2-tumor-bearing mice. First, the <span class="italic">in vivo</span> temperature elevation at the tumor site was recorded by thermography. It could be seen that Cr<small><sub>2</sub></small>N meditated a faster and higher temperature elevation to 56.5 °C after 10 min irradiation, in contrast to only 41 °C without Cr<small><sub>2</sub></small>N (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5a</a>). Moreover, the injection of Vc or not had no influence on the tumor temperature. After the treatment, the antitumor efficiency was judged by the relative tumor volume changes over the following two weeks. The control groups of untreated, NIR-irradiated, and Cr<small><sub>2</sub></small>N-treated mice all showed continuous tumor development, while the mice in the PTT and synergetic PDT/PTT groups were cured with the complete removal of the solid tumor (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5b and d</a>). By comparison, the antitumor outcome of the PDT/PTT group showed very limited advantage over the single PTT action, illustrating that the PTT action played the major role in the antitumor effect on mice. There was no obvious difference in body weight between these groups, which illustrated there were no acute side effects of the phototherapy (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5c</a>).</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-f5.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">
          <span class="italic">In vivo</span> antitumor study. (a) Temperature changes at the tumor site, (b) relative tumor volume, (**<span class="italic">P</span> &lt; 0.01, ANOVA, analysis of variance) (c) relative body weight, (d) representative photographs and (e) H&amp;E staining images of tumors int different groups. (f) H&amp;E staining images of major organs in the phototherapy group.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">Histology analysis of the H&amp;E staining on the tumors harvested from the different groups evidenced severe cancer cell necrosis in the PTT and synergetic PDT/PTT groups, especially for the PDT/PTT groups. This is in accordance with the above tumor-ablation results being related to the photoablation effect of Cr<small><sub>2</sub></small>N (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5e</a>). Meanwhile, H&amp;E staining of the major organs of the mice in the PDT/PTT group revealed no detectable lesions, manifesting the excellent biosafety of the phototherapy (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5f</a>).</p>
      <p class="otherpara">Hemanalysis on the mice after intravenous injection with Cr<small><sub>2</sub></small>N was carried out, including for the blood indicators of white blood cells (WBC), lymphocyte number (LYM), monocytes number (MON), granulocyte count (GRA), hemoglobin (HGB), mean corpuscular hemoglobin (MCH), hemoglobin concentration (MCHC), red blood cells (RBC), mean corpuscular volume (MCV), platelets (PLT), hematocrit (HCT), and plateletcrit (PCT). As can be seen in <a title="Select to navigate to figure" href="#imgfig6">Fig. 6a</a>, all of the blood indicators were within the normal range for the two weeks post injection, which well verified the biosecurity of Cr<small><sub>2</sub></small>N. In <a title="Select to navigate to figure" href="#imgfig6">Fig. 6b</a>, the <span class="italic">in vivo</span> biodistribution results disclosed that the Cr<small><sub>2</sub></small>N mainly was captured by the liver and spleen. It is well known that reticuloendothelial systems in the liver and the spleen could capture the nanoparticles. Then, various enzymes, including neutrophil myeloperoxidase, glucuronic acid or glycine, and metallothionein, would participate in degradation of the nanoparticles. Accordingly, we observed a continuous decrement of Cr<small><sub>2</sub></small>N in the major organs. Meanwhile, the exertion of Cr<small><sub>2</sub></small>N in the urine and feces was found (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6c</a>). These results suggested the body-clearable nature of Cr<small><sub>2</sub></small>N.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-f6.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title">(a) Hematological analysis. (The mice were intravenously injected with Cr<small><sub>2</sub></small>N and the blood was collected on the 1st, 3rd, 7th, and 14th day post injection. The normal range of blood index is shown in the inset.) (b) <span class="italic">In vivo</span> biodistribution of Cr<small><sub>2</sub></small>N and (c) Cr mass in feces and urine.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
      <p class="otherpara">In this work, we speculated that the Cr<small><sub>2</sub></small>N may be turned to Cr ions first and then excreted from the body. To verify this, the degradation of Cr<small><sub>2</sub></small>N in simulated body fluid (SBF) was carried out on 0.5 mg mL<small><sup>−1</sup></small> Cr<small><sub>2</sub></small>N solution in SBF (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7</a>). After being heated for 12 h at 37 °C, Cr<small><sub>2</sub></small>N solution in SBF was centrifuged to separate the Cr<small><sub>2</sub></small>N nanoparticles and the supernatant was harvested. Then, the absorbance of the supernatant was analyzed with a spectrophotometer. It is known that Cr<small><sup>3+</sup></small> ions have a typical absorptive peak at 427 nm, as shown by the control of Cr(NO<small><sub>3</sub></small>)<small><sub>3</sub></small> solution. The Cr<small><sub>2</sub></small>N-degraded supernatant showed distinct photoabsorption at 427 nm after 3, 6, and 12 h as well, suggesting that Cr<small><sub>2</sub></small>N could be degraded into Cr ions gradually. Hence, it is reasonable to understand that Cr<small><sub>2</sub></small>N is a body-clearable nanomaterial. The toxicity of Cr element was related to the chemical valence of Cr ions. Hexavalent chromium is poisonous and carcinogenic because it can reduce the enzymatic activity of glutathione reductase and then oxidize hemoglobin to methemoglobin, thus inhibiting the oxygen carrying capacity; while for the metallic Cr and Cr<small><sup>3+</sup></small> ions, there is nearly no harmful effects to the human body and they are not considered toxic. Trivalent chromium (Cr<small><sup>3+</sup></small>) is a beneficial element for the human body and it plays an important role in the metabolism of glucose, insulin, and lipid. Trivalent chromium ion is an essential nutrient in trace amounts in humans and its nourishment often contains Cr<small><sup>3+</sup></small> for chromium supplementation. In this work, the degradation of Cr<small><sub>2</sub></small>N into Cr<small><sup>3+</sup></small> was confirmed, which could well explain the limited cytotoxicity, hematotoxicity, and tissue toxicity of Cr<small><sub>2</sub></small>N.</p>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig7"><a href="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d0nj03943h-f7.tif" src="/image/article/2020/NJ/d0nj03943h/d0nj03943h-f7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 7 </b> <span id="fig7"><span class="graphic_title">UV-Visible absorbance of Cr(NO<small><sub>3</sub></small>)<small><sub>3</sub></small> solution and Cr<small><sub>2</sub></small>N degradation in simulated body fluid (SBF) for varied times.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      
      <h2 id="sect685"><span class="a_heading">4. Conclusions</span></h2>
      <span>In this work, we selected Cr<small><sub>2</sub></small>N for the phototherapy for consideration of its body-degradable property and dual phototherapeutic outcome. Cr<small><sub>2</sub></small>N showed photoabsorption in a wide range from 300–1400 nm. Under NIR irradiation, the generation of ROS and heat by Cr<small><sub>2</sub></small>N was found to be able to facilitate a synergetic photothermal and photodynamic effect. The antitumor outcome of PTT was confirmed to be more effective than PDT in both <span class="italic">in vitro</span> cell tests and <span class="italic">in vivo</span> with a solid tumor. Cr<small><sub>2</sub></small>N had high biocompatibility in terms of low cytotoxicity, hematotoxicity, and tissue toxicity. Finally, Cr<small><sub>2</sub></small>N was found to be a body-clearable material that could be degraded <span class="italic">in vivo</span> and exerted <span class="italic">via</span> excrement. Thus, Cr<small><sub>2</sub></small>N was demonstrated to be a multifunctional photoactive material that could reduce the operative risk of phototherapy.</span>
    
    
      <h2 id="sect699"><span class="a_heading">Conflicts of interest</span></h2>
      <span>There are no conflicts to declare.</span>
    
  
    <h2 id="sect703"><span class="a_heading">Acknowledgements</span></h2>
      <span>This work is supported by Heilongjiang Provincial Natural Science Foundation of China (LH2019E046)</span>
    
    <span id="sect705"><h2 id="sect702"><span class="a_heading">References</span></h2></span><ol type="1">
      <li><span id="cit1">J. D. Shao, C. S. Ruan, H. H. Xie, Z. B. Li, H. Y. Wang, P. K. Chu and X. F. Yu, <span class="italic">Adv. Sci.</span>, 2018, <span class="bold">5</span>, 1700848 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201700848" title="DOI Link to resource 10.1002/advs.201700848">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/1_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit2">Q. Q. Yu, Y. M. Han, X. C. Wang, C. Qin, D. Zhai, Z. F. Yi, J. Chang, Y. Xiao and C. T. Wu, <span class="italic">ACS Nano</span>, 2018, <span class="bold">12</span>, 2695 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b08928" title="DOI Link to resource 10.1021/acsnano.7b08928">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXktFSqu7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/2_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit3">J. Jin, M. Y. Guo, J. M. Liu, J. Liu, H. G. Zhou, J. Y. Li, L. M. Wang, H. B. Liu, Y. L. Li, Y. L. Zhao and C. Y. Chen, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2018, <span class="bold">10</span>, 8436 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.7b17219" title="DOI Link to resource 10.1021/acsami.7b17219">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXjtVWgsrw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/3_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit4">J. R. Peng, Y. Xiao, W. T. Li, Q. Yang, L. W. Tan, Y. P. Jia and Z. Y. Qian, <span class="italic">Adv. Sci.</span>, 2018, <span class="bold">5</span>, 1700891 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201700891" title="DOI Link to resource 10.1002/advs.201700891">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/4_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit5">Q. Guan, L. Zhou, Y. Li, W. Li, S. Wang, C. Song and Y. Dong, <span class="italic">ACS Nano</span>, 2019, <span class="bold">13</span>, 13304 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.9b06467" title="DOI Link to resource 10.1021/acsnano.9b06467">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitFSqtr7J" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/5_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit6">X. Li, L. Liu, S. Li, Y. Wan, J. Chen, S. Tian, Z. Huang, Y. Xiao, X. Cui and C. Xiang, <span class="italic">ACS Nano</span>, 2019, <span class="bold">13</span>, 12901 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.9b05383" title="DOI Link to resource 10.1021/acsnano.9b05383">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitVymsr3E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/6_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit7">J. Yang, R. Xie, L. Feng, B. Liu, R. Lv, C. Li, S. Gai, F. He, P. Yang and J. Lin, <span class="italic">ACS Nano</span>, 2019, <span class="bold">13</span>, 13144 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.9b05985" title="DOI Link to resource 10.1021/acsnano.9b05985">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhvFKksb3I" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/7_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit8">Q. Wang, H. Wang, Y. Yang, L. Jin, Y. Liu, Y. Wang, X. Yan, J. Xu, R. Gao and P. Lei, <span class="italic">Adv. Mater.</span>, 2019, <span class="bold">31</span>, 1904836 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201904836" title="DOI Link to resource 10.1002/adma.201904836">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKkurrM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/8_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit9">Z. Wang, F. Zhang, D. Shao, Z. Chang, L. Wang, H. Hu, X. Zheng, X. Li, F. Chen and Z. Tu, <span class="italic">Adv. Sci.</span>, 2019, <span class="bold">6</span>, 1901690 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201901690" title="DOI Link to resource 10.1002/advs.201901690">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXisVartrfM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/9_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit10">J. Zhou, Q. L. Wang, S. Z. Geng, R. Lou, Q. W. Yin and W. R. Ye, <span class="italic">Mater. Sci. Eng., C</span>, 2019, <span class="bold">102</span>, 541 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.msec.2019.04.088" title="DOI Link to resource 10.1016/j.msec.2019.04.088">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXovVOls7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/10_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit11">W. P. Fan, B. Shen, W. B. Bu, X. P. Zheng, Q. J. He, Z. W. Cui, D. L. Ni, K. L. Zhao, S. J. Zhang and J. L. Shi, <span class="italic">Biomaterials</span>, 2015, <span class="bold">69</span>, 89 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2015.08.017" title="DOI Link to resource 10.1016/j.biomaterials.2015.08.017">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtlSnu73M" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/11_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit12">S. Kim, M. J. Moon, S. P. Surendran and Y. Y. Jeong, <span class="italic">Pharmaceutics</span>, 2019, <span class="bold">11</span>, 306 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/pharmaceutics11070306" title="DOI Link to resource 10.3390/pharmaceutics11070306">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXjslenu7c%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/12_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit13">D. Chang, M. Lim, J. Goos, R. Qiao, Y. Y. Ng, F. M. Mansfeld, M. Jackson, T. P. Davis and M. Kavallaris, <span class="italic">Front. Pharmacol.</span>, 2018, <span class="bold">9</span>, 831 <a target="_blank" class="DOILink" href="https://doi.org/10.3389/fphar.2018.00831" title="DOI Link to resource 10.3389/fphar.2018.00831">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/13_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit14">K. Ni, T. Aung, S. Li, N. Fatuzzo, X. Liang and W. Lin, <span class="italic">Chemistry</span>, 2019, <span class="bold">5</span>, 1892 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.chempr.2019.05.013" title="DOI Link to resource 10.1016/j.chempr.2019.05.013">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGrtLjF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/14_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit15">Z. Chen, L. Liu, R. Liang, Z. Luo, H. He, Z. Wu, H. Tian, M. Zheng, Y. Ma and L. Cai, <span class="italic">ACS Nano</span>, 2018, <span class="bold">12</span>, 8633 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.8b04371" title="DOI Link to resource 10.1021/acsnano.8b04371">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWgtbfF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/15_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit16">M. Wang, J. Song, F. Zhou, A. R. Hoover, C. K. Murray, B. Zhou, L. Wang, J. Qu and W. R. Chen, <span class="italic">Adv. Sci.</span>, 2019, <span class="bold">6</span>, 1802157 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201802157" title="DOI Link to resource 10.1002/advs.201802157">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/16_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit17">C. Y. Yang, W. C. Huang, Y. Gao, Z. Liu, N. An, W. Mu, Q. M. Pan, B. Yang, C. S. Guo and X. J. Han, <span class="italic">Chem. Eng. J.</span>, 2020, <span class="bold">386</span>, 123961 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.cej.2019.123961" title="DOI Link to resource 10.1016/j.cej.2019.123961">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXjvFGisg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/17_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit18">G. L. Li, C. S. Guo, M. Yan and S. Q. Liu, <span class="italic">Appl. Catal., B</span>, 2016, <span class="bold">183</span>, 142 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.apcatb.2015.10.039" title="DOI Link to resource 10.1016/j.apcatb.2015.10.039">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhslCmsbvK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/18_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit19">W. C. Huang, H. X. Meng, Y. Gao, J. X. Wang, C. Y. Yang, D. Q. Liu, J. Liu, C. S. Guo, B. Yang and W. W. Cao, <span class="italic">J. Mater. Chem. A</span>, 2019, <span class="bold">7</span>, 18538 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9TA03151K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9TA03151K">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/19_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit20">Q. Zhang, W. C. Huang, C. Y. Yang, F. Wang, C. Q. Song, Y. Gao, Y. F. Qiu, M. Yan, B. Yang and C. S. Guo, <span class="italic">Biomater. Sci.</span>, 2019, <span class="bold">7</span>, 2729 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9BM00239A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9BM00239A">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/20_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit21">W. Guo, C. S. Guo, N. N. Zheng, T. D. Sun and S. Q. Liu, <span class="italic">Adv. Mater.</span>, 2017, <span class="bold">29</span>, 1604157 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201604157" title="DOI Link to resource 10.1002/adma.201604157">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/21_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit22">Y. J. Chen, S. H. Wang, Y. Hao, J. B. Pu, X. Jiang, L. F. Huang and L. P. Wang, <span class="italic">Tribol. Int.</span>, 2020, <span class="bold">143</span>, 106079 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.triboint.2019.106079" title="DOI Link to resource 10.1016/j.triboint.2019.106079">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitlWqtbfI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/22_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit23">H. Li, Z. L. Liu, J. L. Li, J. W. Huang, J. Kong, Q. J. Wu and D. S. Xiong, <span class="italic">Surf. Coat. Technol.</span>, 2020, <span class="bold">397</span>, 126067 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.surfcoat.2020.126067" title="DOI Link to resource 10.1016/j.surfcoat.2020.126067">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhtFOitbjM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/23_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit24">W. Ren, Y. Yan, L. Zeng, Z. Shi, A. Gong, P. Schaaf, D. Wang, J. Zhao, B. Zou and H. Yu, <span class="italic">Adv. Healthcare Mater.</span>, 2015, <span class="bold">4</span>, 1526 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adhm.201500273" title="DOI Link to resource 10.1002/adhm.201500273">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXovVCks7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/24_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit25">Y. L. Liu, K. L. Ai, J. H. Liu, M. Deng, Y. Y. He and L. H. Lu, <span class="italic">Adv. Mater.</span>, 2013, <span class="bold">25</span>, 1353 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201204683" title="DOI Link to resource 10.1002/adma.201204683">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhvVyhs7fO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/25_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit26">C. M. Hessel, V. P. Pattani, M. Rasch, M. G. Panthani, B. Koo, J. W. Tunnell and B. A. Korgel, <span class="italic">Nano Lett.</span>, 2011, <span class="bold">11</span>, 2560 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nl201400z" title="DOI Link to resource 10.1021/nl201400z">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXlvFClsbY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/26_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit27">X. Q. Huang, S. H. Tang, X. L. Mu, Y. Dai, G. X. Chen, Z. Y. Zhou, F. X. Ruan, Z. L. Yang and N. F. Zheng, <span class="italic">Nat. Nanotechnol.</span>, 2010, <span class="bold">6</span>, 28 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nnano.2010.235" title="DOI Link to resource 10.1038/nnano.2010.235">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/27_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit28">Y. Cao, Y. N. Wu, G. N. Wang, J. W. Yi, C. L. Yu, Y. X. Huang, L. G. Sun, Y. L. Bao and Y. X. Li, <span class="italic">J. Mater. Chem. B</span>, 2017, <span class="bold">5</span>, 5479 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7TB01264K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7TB01264K">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/28_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit29">M. Q. Chu, Y. X. Shao, J. L. Peng, X. Y. Dai, H. K. Li, Q. S. Wu and D. L. Shi, <span class="italic">Biomaterials</span>, 2013, <span class="bold">34</span>, 4078 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2013.01.086" title="DOI Link to resource 10.1016/j.biomaterials.2013.01.086">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXjsFOnt7c%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/29_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit30">T. Bao, W. Y. Yin, X. P. Zheng, X. Zhang, J. Yu, X. H. Dong, Y. Yong, F. P. Gao, L. Yan, Z. J. Gu and Y. L. Zhao, <span class="italic">Biomaterials</span>, 2016, <span class="bold">76</span>, 11 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2015.10.048" title="DOI Link to resource 10.1016/j.biomaterials.2015.10.048">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhs1yktLfO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/30_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit31">W. T. Wu, X. D. Shao, J. Z. Zhao and M. B. Wu, <span class="italic">Adv. Sci.</span>, 2017, <span class="bold">4</span>, 1700113 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201700113" title="DOI Link to resource 10.1002/advs.201700113">CrossRef</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/31_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit32">C. Song, C. Yang, F. Wang, D. Ding, Y. Gao, W. Guo, M. Yan, S. Liu and C. Guo, <span class="italic">J. Mater. Chem. B</span>, 2017, <span class="bold">5</span>, 9015 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7TB02648J&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7TB02648J">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/32_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
      <li><span id="cit33">W. Huang, H. Meng, Y. Gao, J. Wang, C. Yang, D. Liu, J. Liu, C. Guo, B. Yang and W. Cao, <span class="italic">J. Mater. Chem. A</span>, 2019, <span class="bold">7</span>, 18538 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9TA03151K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9TA03151K">RSC</a> <a target="_blank" class="URLLink" href="/en/Content/OpenURL/50000925/d0nj03943h/33_1" title="Link via OpenURL Resolver"><img height="14px" alt="" src="/en/Image/GetOpenURLImage/50000925"/></a>.</span></li>
    </ol>
    
    
    
    
    
  <hr/><table><tr><td><h3>Footnotes</h3></td></tr><tr><td><span class="sup_ref">† <span id="fn1">Electronic supplementary information (ESI) available. See DOI: <a href="http://xlink.rsc.org/?DOI=d0nj03943h" target="_blank" title="Select to resolve DOI: 10.1039/d0nj03943h">10.1039/d0nj03943h</a></span></span></td></tr><tr><td><span class="sup_ref">‡ <span id="fn2">Yutuo Fu, Le Wang and Xiaoyu Chi contributed equally to this study.</span></span></td></tr></table><table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2020</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>